Paratek Pharmaceuticals and Optinose, Inc. (NASDAQ:OPTN) today announced they have entered into a definitive merger agreement under which Paratek will acquire Optinose, including its approved product ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback